Cargando…

Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients

This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of therapeutic concentrations between 10–20 mcg/mL among 56 pediatric oncology patients. Twelve patients (21%) achieved therapeutic concentrations of 10–20 mcg/mL, while 44 patients (79%) obtained trough lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orr, Hillary, Trone, Deni, Elder, Joshua, Raj, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615269/ https://www.ncbi.nlm.nih.gov/pubmed/28846665 http://dx.doi.org/10.3390/children4090079

Ejemplares similares

Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
por: Libuit, Jessica, et al.
Publicado: (2014)

An Evaluation of Systemic Vancomycin Dosing in Obese Patients
por: Kubiak, David W., et al.
Publicado: (2015)

Results of Four-Year Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection
por: Aktürk, Hacer, et al.
Publicado: (2016)

Omicron variant of SARS‐CoV‐2, an epidemiologic assessment of pediatric oncology patients in the Bronx
por: Offenbacher, Rachel, et al.
Publicado: (2022)

Assessing Clinical Outcomes of Vancomycin Treatment in Adult Patients with Vancomycin-Susceptible Enterococcus faecium Bacteremia
por: Sasano, Hiroshi, et al.
Publicado: (2023)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
por: Kim, Dae Il, et al.
Publicado: (2010)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
por: Bradley, Nicole, et al.
Publicado: (2023)

The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
por: Hall, Ronald G., et al.
Publicado: (2022)

Different Antimicrobial Susceptibility Testing Methods to Determine Vancomycin Susceptibility and MIC for Staphylococcus aureus with Reduced Vancomycin Susceptibility
por: Chung, Hae-Sun, et al.
Publicado: (2022)

Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study
por: Liu, Jiajun, et al.
Publicado: (2020)

An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents
por: Broome, Laura, et al.
Publicado: (2011)

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
por: Katip, Wasan, et al.
Publicado: (2016)

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
por: Bunnell, Kristen L., et al.
Publicado: (2017)

Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis
por: Shen, Bo
Publicado: (2021)

Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant
por: Stripling, Joshua, et al.
Publicado: (2015)

In Outpatients Receiving Parenteral Vancomycin, Dosing Adjustments Produced by Area Under the Curve-Based and Trough-Based Monitoring Differ Only at the Extremes of the Therapeutic Trough Range
por: Shi, Yufei, et al.
Publicado: (2023)

A Prospective Study to Assess Vancomycin Serum Concentrations inPediatric Patients with Current Dosing Guidelines
por: Arfa, Peyman, et al.
Publicado: (2016)

Vancomycin or Daptomycin for Outpatient Parenteral Antibiotic Therapy: Does It Make a Difference in Patient Satisfaction?
por: Wu, Katherine H, et al.
Publicado: (2021)

Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients
por: Hristova, Preslava M., et al.
Publicado: (2023)

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
por: Wilson, F. Perry, et al.
Publicado: (2012)

Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?
por: Aminzadeh, Zohreh, et al.
Publicado: (2014)

Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
por: Johnson, Jennifer A., et al.
Publicado: (2015)

Bilateral endogenous endophthalmitis caused by vancomycin-resistant Staphylococcus epidermidis in a neonate
por: Relhan, Nidhi, et al.
Publicado: (2015)

Vancomycin Dosing in Neutropenic Patients
por: Haeseker, Michiel B., et al.
Publicado: (2014)

Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results
por: Kim, Byungwook, et al.
Publicado: (2023)

Comparison of Acute Kidney Injury During Treatment with Vancomycin and either Piperacillin-Tazobactam or Meropenem
por: Cannon, John M., et al.
Publicado: (2017)

Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
por: Hricová, Kristýna, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients
por: Shoji, Kensuke, et al.
Publicado: (2021)

Assessment of Oropharyngeal Specimens for Discontinuation of Transmission-Based COVID-19 Precautions
por: Barocas, Joshua A, et al.
Publicado: (2020)

WeWhoCurie: An Initiative to Advocate for Those Underrepresented in Radiation Oncology
por: Ogunmuyiwa, Joy, et al.
Publicado: (2022)

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
por: Mcgrady, Kerri A., et al.
Publicado: (2020)

Comparing patient and family usability of insertable cardiac monitors in a pediatric cohort: Patient external activator versus smartphone transmission
por: Lorimer, Dean, et al.
Publicado: (2021)

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010)

Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
por: Barlow, Ashley, et al.
Publicado: (2021)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

280. The Impact of a Revised Neutropenic Fever Guideline on Vancomycin-Resistant Enterococcus Rates in Pediatric Oncology Patients
por: Karandikar, Manjiree, et al.
Publicado: (2018)

Continuous Learning in Model‐Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin
por: Hughes, Jasmine H., et al.
Publicado: (2020)

A Pilot Survey of Integrative Oncology in Hospitalized Children Undergoing Aggressive Therapy for Cancer and Blood Disorders at a Single Pediatric Cancer Center
por: Kawashima, Nozomu
Publicado: (2023)

Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient
por: Amin, Nimisha, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pm1d42dc35di1g00vejrej45jm